Veristat, a leading global clinical research organization (CRO) and consultancy, proudly congratulates George Medicines on the U.S. Food and Drug Administrat ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of hypertension in adults, including as initial treatment.

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

1. Widaplik — manufactured by George Medicines — is a polypill that contains telmisartan, amlodipine and indapamide. 2. Historically, monotherapies have been the initial treatment for ...

George Medicines announced that the FDA approved Widaplik (telmisartan, amlodipine and indapamide) for hypertension in adults, including initial treatment. FDA moved to restrict the use of Merck ’s ...

WEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

The FDA has approved George Medicines’ Widaplik (telmisartan, amlodipine, and indapamide), a novel single-pill triple combination therapy for hypertension in adults, including for initial treatment.

WIDAPLIK is contraindicated in patients with anuria, known hypersensitivity to telmisartan, amlodipine, indapamide, or to other sulfonamide-derived drugs, or to any other component of this product.

In late-stage trials, George Medicines weighed Widaplik against placebo and dual combinations of telmisartan, amlodipine and indapamide.

WIDAPLIK is a combination tablet of telmisartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker and indapamide, a thiazide-like diuretic, available in ...